Silvant Capital Management LLC Biogen Inc. Transaction History

Silvant Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 05, 2022	SELL	$193.77 - $244.14 $31,778 - $40,038	-164 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$217.44 - $243.88 $7,827 - $8,779	-36 Reduced 18.0%	164 $38,000
Q1 2019 May 10, 2019	SELL	$216.71 - $338.96 $3.7 Million - $5.79 Million	-17,068 Reduced 98.84%	200 $47,000
Q4 2018 Feb 06, 2019	SELL	$278.5 - $352.75 $135,351 - $171,436	-486 Reduced 2.74%	17,268 $5.2 Million
Q3 2018 Nov 07, 2018	SELL	$293.51 - $383.83 $848,537 - $1.11 Million	-2,891 Reduced 14.0%	17,754 $6.27 Million
Q2 2018 Aug 13, 2018	SELL	$257.52 - $306.91 $60,002 - $71,510	-233 Reduced 1.12%	20,645 $5.99 Million
Q1 2018 May 09, 2018	BUY	$260.13 - $367.91 $5.43 Million - $7.68 Million	20,878 New	20,878 $5.72 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Silvant Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Silvant Capital Management LLC with notifications on news.